Targeting the epitope spreader Pep19 by naïve human CD45RA+ regulatory T cells dictates a distinct suppressive T cell fate in a novel form of immunotherapy.
about
Targeting the epitope spreader Pep19 by naïve human CD45RA+ regulatory T cells dictates a distinct suppressive T cell fate in a novel form of immunotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Targeting the epitope spreader ...... a novel form of immunotherapy.
@en
Targeting the epitope spreader ...... a novel form of immunotherapy.
@nl
type
label
Targeting the epitope spreader ...... a novel form of immunotherapy.
@en
Targeting the epitope spreader ...... a novel form of immunotherapy.
@nl
prefLabel
Targeting the epitope spreader ...... a novel form of immunotherapy.
@en
Targeting the epitope spreader ...... a novel form of immunotherapy.
@nl
P2093
P2860
P50
P1476
Targeting the epitope spreader ...... a novel form of immunotherapy
@en
P2093
Gil Sun Cha
Hyun-Joo Kim
Jeomil Choi
Jeongae Lee
Ji-Young Joo
Juyoun Lee
So Youn Park
Sung-Jo Kim
P2860
P304
P356
10.5051/JPIS.2017.47.5.292
P577
2017-10-30T00:00:00Z